Michiteru Ohtani
- Biological Psychiatry top 5%
- Pharmacology top 5%
- Pharmacy and Medical Practices 13
- Treatment of Major Depression 4
- Pharmacological Effects of Natural Compounds 3
- Toxicology top 5%
- Pharmacology top 5%
- Pharmacy and Medical Practices 13
- Treatment of Major Depression 4
- Pharmacological Effects of Natural Compounds 3
-
- Pharmacological Receptor Mechanisms and Effects 4
- Biopolymer Synthesis and Applications 3
-
- Food Quality and Safety Studies 4
-
- Dermatology and Skin Diseases 3
-
- Neuropeptides and Animal Physiology 3
- Co-authors
- Katsuyoshi UchinoSatoru KariyaYoshikazu YamamuraYoshitsugu YanagiharaTatsuji IgaTakao AoyamaHajime KotakiKenji Nishitateno
- Journals
- Journal of Pharmacology and Experimental Therapeutics (1 paper)Experimental Brain Research (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)
- Partner nations
- JapanUnited StatesSerbia
In The Last Decade
Michiteru Ohtani
34 papers receiving 590 citations
Peers
Comparison fields: 5 of 88
- Biological Psychiatry 86
- Anesthesiology and Pain Medicine 144
- Pharmacology 224
- Toxicology 45
- Pharmacology 105
Countries citing papers authored by Michiteru Ohtani
This map shows the geographic impact of Michiteru Ohtani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiteru Ohtani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiteru Ohtani more than expected).
Fields of papers citing papers by Michiteru Ohtani
This network shows the impact of papers produced by Michiteru Ohtani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiteru Ohtani. The network helps show where Michiteru Ohtani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michiteru Ohtani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 2 | |
| 2 | 2013 | 4 | |
| 3 | [Fall risk and fracture. Drugs that affect the fall or fracture]. | 2013 | 1 |
| 4 | 2012 | 0 | |
| 5 | Evaluation of the Pharmaceutical Equivalency by Concentration of Steroid in Bases and the Permeability of Genuine and Generic Commercially Available Steroidal Formulations | 2011 | 1 |
| 6 | 2011 | 3 | |
| 7 | 2010 | 1 | |
| 8 | 2009 | 2 | |
| 9 | 2008 | 7 | |
| 10 | 2004 | 5 | |
| 11 | 2002 | 0 | |
| 12 | 2002 | 156 | |
| 13 | 2001 | 1 | |
| 14 | 2000 | 35 | |
| 15 | 1999 | 8 | |
| 16 | 1997 | 5 | |
| 17 | 1997 | 116 | |
| 18 | 1997 | 7 | |
| 19 | 1993 | 7 | |
| 20 | 1989 | 28 |
About Michiteru Ohtani
Michiteru Ohtani is a scholar working on Pharmacology, Dermatology and Pharmaceutical Science, having authored 38 papers that have together received 624 indexed citations. Recurring topics across this work include Pharmacy and Medical Practices (13 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Food Quality and Safety Studies (4 papers), Treatment of Major Depression (4 papers), Dermatology and Skin Diseases (3 papers), Biopolymer Synthesis and Applications (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Biological Psychiatry (86 citations), Anesthesiology and Pain Medicine (144 citations) and Pharmacology (224 citations). Michiteru Ohtani has collaborated with scholars based in Japan, United States and Serbia. Frequent co-authors include Katsuyoshi Uchino, Satoru Kariya, Yoshikazu Yamamura, Yoshitsugu Yanagihara, Tatsuji Iga, Takao Aoyama, Hajime Kotaki, Kenji Nishitateno, Tatsuji Iga and Yasufumi Sawada. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Experimental Brain Research and Chemical and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.